Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

What if immunotherapy could be delivered exactly where its needed most? #shorts

14 Feb 2026 · 1 min

Watch on YouTube

0:36

In this short video, the presenter introduces Chemoimmunoprecision Injection (cipi), a novel precision oncology technique that uses interventional radiology to deliver immunotherapy directly into solid tumors. By employing ultra‑small catheters or percutaneous needles—described as “invisible surgery”—the method aims to target the immune system’s drugs precisely where they are needed, eliminating large surgical incisions and reducing invasiveness. The speaker emphasizes that this minimally invasive approach could represent a critical milestone in cancer treatment by improving drug delivery and immune targeting while leaving patients with only a small band‑aid after the procedure.

Chapters

Today I'm going to break down an exciting breakthrough in oncology. Chemoimmunoprecision injection, or what we call cipi, represents a critical milestone in precision oncology. For most solid tumors, this is using the state of the art and interventional radiology oncology to change cancer. Here's what the key is. It's the immune system and it's getting the medicine to the right parts of the body. This directed tumor technology, it's minimally invasive. We call it invisible surgery because essentially you come out with a band aid and you're using a catheter the size of your hair, or you're going pericutaneous with a tiny needle to the tumor. So it's very small. There's not the surgical cut, there's not the opening, there's none of that. It's really direct.